Lara Mittereder

1.0k total citations · 1 hit paper
21 papers, 753 citations indexed

About

Lara Mittereder is a scholar working on Infectious Diseases, Molecular Biology and Immunology. According to data from OpenAlex, Lara Mittereder has authored 21 papers receiving a total of 753 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 13 papers in Molecular Biology and 8 papers in Immunology. Recurrent topics in Lara Mittereder's work include Bacillus and Francisella bacterial research (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Tuberculosis Research and Epidemiology (5 papers). Lara Mittereder is often cited by papers focused on Bacillus and Francisella bacterial research (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Tuberculosis Research and Epidemiology (5 papers). Lara Mittereder collaborates with scholars based in United States, Brazil and South Africa. Lara Mittereder's co-authors include Alan Sher, Sivaranjani Namasivayam, Diego L. Costa, Eduardo P. Amaral, Bruno B. Andrade, Nicolas Riteau, Olena Kamenyeva, Katrin D. Mayer-Barber, Sara Hieny and Vishal Thovarai and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and PLoS ONE.

In The Last Decade

Lara Mittereder

20 papers receiving 750 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A major role for ferroptosis in Mycobacterium tuberculosis–induced cell death and tissue necrosis

2019 310 citations Eduardo P. Amaral, Diego L. Costa et al. The Journal of Experimental Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lara Mittereder United States	12	447	278	182	176	163	21	753
Zhaoti Wang United States	9	224 0.5×	129 0.5×	356 2.0×	133 0.8×	46 0.3×	9	672
Marilena P. Etna Italy	15	333 0.7×	437 1.6×	324 1.8×	382 2.2×	38 0.2×	26	1.0k
Jesus A. Segovia United States	13	438 1.0×	105 0.4×	291 1.6×	343 1.9×	87 0.5×	15	838
Kailang Wu China	14	439 1.0×	304 1.1×	128 0.7×	145 0.8×	47 0.3×	20	897
Haripriya Sridharan United States	7	1.0k 2.2×	131 0.5×	330 1.8×	814 4.6×	73 0.4×	7	1.4k
Justin P. Ingram United States	8	640 1.4×	101 0.4×	168 0.9×	513 2.9×	62 0.4×	16	916
Joseph S. Bednash United States	15	396 0.9×	262 0.9×	68 0.4×	173 1.0×	72 0.4×	34	770
Mushtaq Ahmed United States	15	177 0.4×	451 1.6×	297 1.6×	539 3.1×	33 0.2×	44	957
Simon H. Apte Australia	15	243 0.5×	62 0.2×	72 0.4×	266 1.5×	61 0.4×	43	665
Ramona Hurdayal South Africa	14	157 0.4×	184 0.7×	267 1.5×	259 1.5×	31 0.2×	19	729

Countries citing papers authored by Lara Mittereder

Since Specialization

Citations

This map shows the geographic impact of Lara Mittereder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lara Mittereder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lara Mittereder more than expected).

Fields of papers citing papers by Lara Mittereder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lara Mittereder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lara Mittereder. The network helps show where Lara Mittereder may publish in the future.

Co-authorship network of co-authors of Lara Mittereder

This figure shows the co-authorship network connecting the top 25 collaborators of Lara Mittereder. A scholar is included among the top collaborators of Lara Mittereder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lara Mittereder. Lara Mittereder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Elkins, Karen L., Lara Mittereder, Roberto De Pascalis, et al.. (2025). Vaccination with a novel live attenuated strain of Francisella tularensis subsp. tularensis protects cynomolgus macaques against aerosol F. tularensis infection. Vaccine. 62. 127523–127523.

Kurtz, Sherry L., Richard E. Baker, Frederick J. Boehm, et al.. (2024). Multiple genetic loci influence vaccine-induced protection against Mycobacterium tuberculosis in genetically diverse mice. PLoS Pathogens. 20(3). e1012069–e1012069. 7 indexed citations

Mittereder, Lara, Jonathan G. Swoboda, Roberto De Pascalis, & Karen L. Elkins. (2023). IL-12p40 is essential but not sufficient for Francisella tularensis LVS clearance in chronically infected mice. PLoS ONE. 18(3). e0283161–e0283161. 1 indexed citations

Namasivayam, Sivaranjani, Matthew Zimmerman, Sandra D. Oland, et al.. (2023). The Dysbiosis Triggered by First-Line Tuberculosis Antibiotics Fails to Reduce Their Bioavailability. mBio. 14(2). e0035323–e0035323. 5 indexed citations

Kurtz, Sherry L., et al.. (2023). Intravenous BCG Vaccination of Diversity Outbred Mice Results in Moderately Enhanced Protection against Challenge with Mycobacterium tuberculosis Compared to Intradermal Vaccination. Infection and Immunity. 91(7). e0016823–e0016823. 9 indexed citations

Bomfim, Caio César Barbosa, Logan Fisher, Eduardo P. Amaral, et al.. (2022). Mycobacterium tuberculosis Induces Irg1 in Murine Macrophages by a Pathway Involving Both TLR-2 and STING/IFNAR Signaling and Requiring Bacterial Phagocytosis. Frontiers in Cellular and Infection Microbiology. 12. 862582–862582. 32 indexed citations

Costa, Diego L., Eduardo P. Amaral, Sivaranjani Namasivayam, et al.. (2021). Enhancement of CD4+ T Cell Function as a Strategy for Improving Antibiotic Therapy Efficacy in Tuberculosis: Does It Work?. Frontiers in Cellular and Infection Microbiology. 11. 672527–672527. 5 indexed citations

Mittereder, Lara, Kevin Tosh, Daniel J. Green, et al.. (2021). IFNs Reset the Differential Capacity of Human Monocyte Subsets to Produce IL-12 in Response to Microbial Stimulation. The Journal of Immunology. 206(7). 1642–1652. 3 indexed citations

Costa, Diego L., Eduardo P. Amaral, Sivaranjani Namasivayam, et al.. (2020). Heme oxygenase-1 inhibition promotes IFNγ- and NOS2-mediated control of Mycobacterium tuberculosis infection. Mucosal Immunology. 14(1). 253–266. 24 indexed citations

10.

Pascalis, Roberto De, Lara Mittereder, Kazuyo Takeda, et al.. (2020). Production of IFN-γ by splenic dendritic cells during innate immune responses against Francisella tularensis LVS depends on MyD88, but not TLR2, TLR4, or TLR9. PLoS ONE. 15(8). e0237034–e0237034. 8 indexed citations

11.

Namasivayam, Sivaranjani, Keith D. Kauffman, John A. McCulloch, et al.. (2019). Correlation between Disease Severity and the Intestinal Microbiome in Mycobacterium tuberculosis-Infected Rhesus Macaques. mBio. 10(3). 31 indexed citations

12.

Amaral, Eduardo P., Diego L. Costa, Sivaranjani Namasivayam, et al.. (2019). A major role for ferroptosis in Mycobacterium tuberculosis–induced cell death and tissue necrosis. The Journal of Experimental Medicine. 216(3). 556–570. 310 indexed citations breakdown →

13.

Pascalis, Roberto De, Patrik Rydén, Lara Mittereder, et al.. (2018). A panel of correlates predicts vaccine-induced protection of rats against respiratory challenge with virulent Francisella tularensis. PLoS ONE. 13(5). e0198140–e0198140. 19 indexed citations

14.

Namasivayam, Sivaranjani, Mamoudou Maïga, Wuxing Yuan, et al.. (2017). Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy. Microbiome. 5(1). 71–71. 103 indexed citations

15.

Pascalis, Roberto De, et al.. (2016). Activities of Murine Peripheral Blood Lymphocytes Provide Immune Correlates That Predict Francisella tularensis Vaccine Efficacy. Infection and Immunity. 84(4). 1054–1061. 17 indexed citations

16.

Riteau, Nicolas, Andrea J. Radtke, Kevin Shenderov, et al.. (2016). Water-in-Oil–Only Adjuvants Selectively Promote T Follicular Helper Cell Polarization through a Type I IFN and IL-6–Dependent Pathway. The Journal of Immunology. 197(10). 3884–3893. 33 indexed citations

17.

Costa, Diego L., Sivaranjani Namasivayam, Eduardo P. Amaral, et al.. (2016). Pharmacological Inhibition of Host Heme Oxygenase-1 Suppresses Mycobacterium tuberculosis Infection In Vivo by a Mechanism Dependent on T Lymphocytes. mBio. 7(5). 46 indexed citations

18.

Pascalis, Roberto De, et al.. (2015). Francisella tularensis Vaccines Elicit Concurrent Protective T- and B-Cell Immune Responses in BALB/cByJ Mice. PLoS ONE. 10(5). e0126570–e0126570. 11 indexed citations

19.

Tosh, Kevin, Lara Mittereder, Sandra Bonne-Année, et al.. (2015). The IL-12 Response of Primary Human Dendritic Cells and Monocytes to Toxoplasma gondii Is Stimulated by Phagocytosis of Live Parasites Rather Than Host Cell Invasion. The Journal of Immunology. 196(1). 345–356. 62 indexed citations

20.

Bennett, Christina N., Christine C. Tomlinson, Aleksandra M. Michalowski, et al.. (2012). Cross-species genomic and functional analyses identify a combination therapy using a CHK1 inhibitor and a ribonucleotide reductase inhibitor to treat triple-negative breast cancer. Breast Cancer Research. 14(4). R109–R109. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact